COVID-19 vaccines webinar - your questions answered

Our guest panel will discuss how COVID-19 vaccines work to develop an immune response, what the immune response consists of, the response to the vaccine by people with lymphoma, ongoing research into this area, and the concerns raised by people with lymphoma in the current environment.

When you register to attend you will have the opportunity to submit a question to our panel in advance.

webinar image

As the rollout of the coronavirus (COVID-19) vaccine continues, news about the immune response to the vaccine by people with blood cancer has caused some concerns, and raised various questions. The changes to the restrictions and guidelines for the country has also had an impact, and some people still feel a level of concern about their situation.


This webinar aims to give an update on the situation with the vaccines and ongoing research into their impact and value for people with lymphoma, and well as addressing some of the concerns of the lymphoma community.


Book your place now (FREE)


Guest panel

In our live webinar we will be joined by a panel of three UK lymphoma experts, who will be addressing your questions about the vaccines:

  • Dr Graham Collins, Consultant Haematologist, Oxford University Hospitals
  • Dr Wendy Osborne, Consultant Haematologist, Freeman Hospital, Newcastle upon Tyne
  • Dr Shirley D’Sa, WM lead clinician, University College London Hospitals

This webinar is for anyone affected by lymphoma in the UK.


Joining the webinar

This webinar is run through GoToWebinar. If you haven't used GoToWebinar before, you might like to join the webinar a few minutes early to ensure you can get connected. (Some devices might require you to download the GoToWebinar app to run the webinar.)


Please note: once you register on GoToWebinar you will be sent a unique joining link, and this will come from GoToWebinar directly (if you don't receive it, please check your email spam box!) You will also receive a reminder one day before, and one hour before, the webinar begins.